• About
  • Subscribe
  • Advertise
  • Contact
Thursday, December 5, 2024
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Business

Marcolin expansion in Australia built on premium eyewear, service

by Staff Writer
November 15, 2024
in Business, Feature, Frames, Report
Reading Time: 4 mins read
A A
Alessandro Marchi, general manager of Marcolin Australia. Image: Marcolin.

Alessandro Marchi, general manager of Marcolin Australia. Image: Marcolin.

Share on FacebookShare on Twitter

Pairing premium eyewear with premium service and support is at the heart of the global company’s strategy in Australia.

In just four years, Italian leading eyewear player Marcolin has established itself within the Australian optical market.

Renowned for its premium, high-end frames, the company has worked hard to pair its product offering with support and service for optometrists.

“You don’t sell in; you sell out. If the optometrist doesn’t sell the product, you don’t get a replenishment order. Success in sales comes from the replenishment, not the first order,” explains Mr Alessandro Marchi, general manager of Marcolin Australia.

This philosophy has been at the core of Marcolin’s business strategy since it opened its Sydney office, focusing on delivering both luxury eyewear and the tools necessary to help its customers thrive in a competitive industry environment.

Founded over six decades ago in Italy’s Veneto region, Marcolin’s portfolio features some of the most prestigious names in fashion, including Tom Ford, Pucci, Guess, Zegna, and Max Mara.

These brands have been introduced to the Australian and New Zealand markets, where Marcolin aims to cater to a broad demographic spectrum by offering an extensive selection of high-end products.

This broad offering was further expanded in 2023, when Marcolin acquired the German eyewear manufacturer ic! berlin GmbH, known for its innovative and stylish frames.

A model wears glasses from the new ic! berlin range. Image: Marcolin

The company is also set to bring new collections from globally acclaimed brands, such as Christian Louboutin and Abercrombie & Fitch, to Australia in 2025.

However, Marcolin believes its success in Australia is not solely attributable to its impressive brand line-up.

The company has placed a strong emphasis on after-sales support and marketing, ensuring that its retail partners, ranging from independent optometrists to boutique stores and department chains, receive tailored solutions.

This includes in-store displays, digital marketing materials, and customised retail strategies designed to meet the unique needs of each business.

“At Marcolin, we believe exceptional service is integral to the long-term success of our retail partners,” says Marchi.

Marcolin’s Australia head office in Sydney. Image: Marcolin.

“We work closely with our clients, offering warranty services, customer care, and post-purchase support to give them and their customers the confidence to continue investing in our products.”

This dedication to service, combined with the company’s premium product offering, has strengthened Marcolin’s reputation as a reliable and professional partner in the luxury eyewear space.

According to Marchi, “when you sell premium brands, you must also provide premium service – the two are inseparable.”

As Australia’s optical market becomes increasingly competitive, he says Marcolin is well-positioned to continue its growth.

The company’s support for independent optometrists and local chains remains a central focus, with its combination of high-quality products and dedicated service offering a significant advantage.

Marcolin’s success in Australia is a testament to its strategic focus on brand excellence, comprehensive support, and customer engagement.

As it continues to introduce new brands and expand its reach, the company believes it is poised to play a leading role in shaping the future of the Australian luxury eyewear market.

More reading

New ic! berlin collection from Marcolin combines cold steel and hot design

Marcolin launches new training and customer experience project using augmented reality

Marcolin 2022 financials reveal net sales growth of 20%

Related Posts

As a practice’s most valued asset, staff need training to ensure the business runs effectively. Image: YAKOBCHUK VIACHESLAV/Shutterstock.com.

Building a strong staff complement – Part 2

by Staff Writer
December 4, 2024

Having a structured approach to the employee lifecycle can set clear expectations and drive staff performance, writes Karen Crouch in...

A Google My Business account is the way practice owners can claim ownership of their business profile. Image: Vladimka production/Shutterstock.com.

Keeping on top of your business directory listings

by Staff Writer
December 3, 2024

Unknown to many practitioners, Google, Microsoft, and Apple have created business directory listings for them without their input or permission....

A low vision patient using an aid to check prices at the supermarket. Image: Vision Australia.

Low vision patients and the moments that matter

by Staff Writer
December 2, 2024

Simply spending a few minutes at the end of a consultation to discuss options with a low vision patient can...

Join our newsletter

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited